bumetanide has been researched along with Deafness in 2 studies
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delpire, E | 1 |
| Lu, J | 1 |
| England, R | 1 |
| Dull, C | 1 |
| Thorne, T | 1 |
| Bourke, E | 1 |
2 other studies available for bumetanide and Deafness
| Article | Year |
|---|---|
Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter.
Topics: Animals; Bumetanide; Carrier Proteins; Cochlea; Deafness; Erythrocytes; Hair Cells, Auditory, Outer; | 1999 |
Letter: Frusemide, bumetanide, and ototoxicity.
Topics: Bumetanide; Deafness; Diuretics; Edema; Female; Furosemide; Humans; Hyperparathyroidism; Male; Middl | 1976 |